Skip to Content
Winter SaleWinter Sale

Advances in Penile and Testicular Cancer, An Issue of Urologic Clinics of North America, 1st Edition

Author :
By , Jeffrey M. Holzbeierlein, MD, FACS and Philippe E. Spiess, MD, MS, FACS, FRCSC
In this issue of Urologic Clinics of North America, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of Advances in Penile and Testicular Cancer. Top experts in the field provide impor ...view more
In this issue of Urologic Clinics of North America, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of Advances in Penile and Testicular Cancer. Top experts in the field provide important clinical updates on the management of penile and scrotal cancer, discuss the current standards of care using evidence-based treatment guidelines, and provide insight on emerging discoveries. This issue provides critical information and updates needed to improve outcomes in patients with diseases that urologists do not see on a daily basis.
ISBN :
9780443246869
Publication Date :
28-08-2024
Stock Status :
Please allow 7-10 working days for delivery
Earn 12 Points
Earn 9 Points
Add to Cart
In this issue of Urologic Clinics of North America, guest editors Drs. Jeffrey M. Holzbeierlein and Philippe E. Spiess bring their considerable expertise to the topic of Advances in Penile and Testicular Cancer. Top experts in the field provide important clinical updates on the management of penile and scrotal cancer, discuss the current standards of care using evidence-based treatment guidelines, and provide insight on emerging discoveries. This issue provides critical information and updates needed to improve outcomes in patients with diseases that urologists do not see on a daily basis.

Key Features
  • Contains 12 relevant, practice-oriented topics, including the psychosocial impact of penile cancer: an unmet need; what is on the horizon in clinical trials for penile and testicular cancer; the use of miRNA to predict teratoma and viable GCT after chemotherapy; testicular cancers survivorship and fertility preservation; and more.
  • Provides in-depth clinical reviews on advances in penile and testicular cancer, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Author Information
By ; Jeffrey M. Holzbeierlein, MD, FACS, Vice President and Physician in Chief, The University of Kansas Cancer Center, Kansas City, KS and Philippe E. Spiess, MD, MS, FACS, FRCSC, Assistant Chief of Surgical Services, Senior Member, Department of GU Oncology, Medical Director, Virtual Care, Moffitt Cancer Center, Tampa, FL, USA